Home › Respiratory Distress Syndrome › Tennessee › Nashville
Respiratory Distress Syndrome clinical trials in Nashville, TN
6 studies for Respiratory Distress Syndrome are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
RecruitingPhase 2
- Vanderbilt University Medical Center, Nashville
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
RecruitingPhase 2
- Vanderbilt University Medical Center, Nashville
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RecruitingPhase 2
- Vanderbilt University Medical Center, Nashville
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RecruitingPhase 2
- Vanderbilt University Medical Center, Nashville
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
RecruitingPhase 3
- Direct Biologics Investigational Site, Nashville
The APS Phenotyping Study
RecruitingObservational study
- Meharry Medical College, Nashville
- Vanderbilt University Medical Center, Nashville
Respiratory Distress Syndrome trials in other cities
- Houston, TX11 studies
- New York City, NY10 studies
- West Jordan, UT9 studies
- Boston, MA8 studies
- Durham, NC8 studies
- Denver, CO8 studies
- Birmingham, AL7 studies
- Ann Arbor, MI7 studies
- Charlottesville, VA7 studies
- The Bronx, NY7 studies
- Cleveland, OH7 studies
- Oklahoma City, OK7 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.